$1.44 Billion is the total value of Perceptive Advisors's 172 reported holdings in Q2 2016. The portfolio turnover from Q1 2016 to Q2 2016 was 72.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SRPT | New | Sarepta Therapeutics Incput | $145,300,000 | – | 7,619,300 | +100.0% | 10.07% | – |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $127,167,000 | +18.2% | 2,797,967 | +2.8% | 8.82% | -6.6% |
| TSRO | Buy | TESARO INC | $96,121,000 | +98.7% | 1,143,615 | +4.1% | 6.66% | +57.1% |
| FOLD | AMICUS | $83,207,000 | -35.4% | 15,239,444 | 0.0% | 5.77% | -48.9% | |
| SRPT | Sell | SAREPTA THERAPEUTICS INC | $71,843,000 | -4.0% | 3,767,316 | -1.7% | 4.98% | -24.1% |
| RTRX | Buy | Retrophin Inc | $58,405,000 | +42.6% | 3,279,380 | +9.3% | 4.05% | +12.7% |
| MDVN | Buy | MEDIVATION INC | $45,828,000 | +193.1% | 760,000 | +123.5% | 3.18% | +131.7% |
| GBT | Buy | GLOBAL BLOOD THERAPEUTICS IN | $36,625,000 | +78.0% | 2,207,668 | +70.2% | 2.54% | +40.7% |
| VSAR | VERSARTIS INC | $31,363,000 | +37.9% | 2,835,754 | 0.0% | 2.17% | +9.0% | |
| NXTM | New | NXSTAGE MEDICAL INC | $29,971,000 | – | 1,382,410 | +100.0% | 2.08% | – |
| LBIO | Buy | LION BIOTECHNOLOGIES INC | $29,257,000 | +106.6% | 3,611,976 | +29.6% | 2.03% | +63.3% |
| XNCR | Sell | XENCOR INC | $29,046,000 | +19.9% | 1,529,574 | -15.2% | 2.01% | -5.2% |
| XBI | New | STREETTRACKS SPDR BIOTEC ETFput | $27,045,000 | – | 500,000 | +100.0% | 1.88% | – |
| NVRO | Buy | NEVRO CORP | $26,939,000 | +37.4% | 365,229 | +4.8% | 1.87% | +8.6% |
| CPXX | Sell | CELATOR PHARMACEUTICALS INC | $25,303,000 | +108.5% | 838,400 | -23.8% | 1.75% | +64.8% |
| LJPC | Buy | LA JOLLA PHARMACEUTICAL CO | $21,325,000 | +45.8% | 1,332,815 | +90.5% | 1.48% | +15.2% |
| XLRN | Sell | ACCELERON | $20,491,000 | -3.3% | 603,036 | -24.9% | 1.42% | -23.6% |
| SRPT | Buy | Sarepta Therapeutics Inccall | $18,673,000 | +73.9% | 979,200 | +78.0% | 1.30% | +37.5% |
| STJ | New | ST JUDE MEDICAL | $18,174,000 | – | 233,000 | +100.0% | 1.26% | – |
| DBVT | Buy | DBV TECHNOLOGIES S Asponsored adr | $17,833,000 | +31.5% | 546,696 | +31.2% | 1.24% | +3.9% |
| QTNT | Buy | QUOTIENT LTD | $17,430,000 | -8.9% | 2,249,067 | +2.7% | 1.21% | -28.0% |
| EVH | Buy | EVOLENT HEALTH INCcl a | $16,763,000 | +156.5% | 873,064 | +41.1% | 1.16% | +102.8% |
| ACRX | ACELRX PHARMA | $16,129,000 | -12.7% | 5,995,760 | 0.0% | 1.12% | -31.0% | |
| DERM | Sell | DERMIRA INC | $13,514,000 | +27.6% | 462,000 | -9.8% | 0.94% | +0.9% |
| VBIV | Sell | VBI VACCINES INC | $12,080,000 | +57.7% | 3,058,433 | -6.2% | 0.84% | +24.6% |
| DEPO | Sell | DEPOMED INC | $11,727,000 | +29.5% | 600,000 | -7.7% | 0.81% | +2.4% |
| EGRX | Buy | EAGLE PHARMACEUTICALS INC | $11,637,000 | +53.5% | 300,000 | +60.2% | 0.81% | +21.4% |
| VRTX | Sell | VERTEX PHARMACEUTICALS INC | $11,183,000 | -12.1% | 130,000 | -18.8% | 0.78% | -30.6% |
| ALDX | Buy | ALDEYRA | $11,041,000 | +112.4% | 1,940,458 | +56.4% | 0.76% | +67.8% |
| WVE | Buy | WAVE LIFE SCIENCES LTD | $10,812,000 | +342.6% | 522,595 | +196.9% | 0.75% | +250.5% |
| CSU | Buy | CAPITAL SR LIVING CORP | $10,357,000 | +2.7% | 586,136 | +7.6% | 0.72% | -18.9% |
| HEDJ | New | WISDOMTREE EUROPE HEDGED EQUput | $10,106,000 | – | 200,000 | +100.0% | 0.70% | – |
| Buy | ALDER BIOPHARMACEUTICALS INC | $9,988,000 | +8.8% | 400,000 | +6.7% | 0.69% | -14.1% | |
| DXCM | Buy | DEXCOM INC | $9,930,000 | +452.3% | 125,174 | +372.8% | 0.69% | +335.4% |
| QURE | Sell | UNIQURE NV | $9,891,000 | -42.3% | 1,342,093 | -6.9% | 0.69% | -54.4% |
| TEVA | Sell | TEVA PHARMACEUTICAL INDS LTDadr | $9,845,000 | -29.5% | 196,000 | -24.9% | 0.68% | -44.2% |
| CRBP | Buy | CORBUS PHARMACEUTICALS HLDGS | $9,568,000 | +323.0% | 3,200,000 | +156.0% | 0.66% | +234.8% |
| BPMC | Buy | BLUEPRINT MEDICINES CORP | $9,404,000 | +28.8% | 464,404 | +14.8% | 0.65% | +1.9% |
| AGTC | Buy | APPLIED GENETIC TECHNOL CORP | $9,309,000 | +2.4% | 658,851 | +1.3% | 0.64% | -19.2% |
| RGNX | Buy | REGENXBIO INC | $8,793,000 | -1.4% | 1,099,213 | +33.2% | 0.61% | -22.0% |
| NERV | MINERVA NEUROSCIENCES INC | $8,275,000 | +66.3% | 810,537 | 0.0% | 0.57% | +31.7% | |
| CDTX | Buy | CIDARA THERAPEUTICS INC | $8,174,000 | -13.4% | 792,857 | +6.7% | 0.57% | -31.4% |
| ANI PHARMACEUTICALS INCnote 3.000%12/ | $8,121,000 | +23.2% | 7,500,000 | 0.0% | 0.56% | -2.6% | ||
| PFNX | PFENEX INC | $8,043,000 | -14.9% | 960,877 | 0.0% | 0.56% | -32.7% | |
| CTMX | CYTOMX THERAPEUTICS INC | $7,579,000 | -20.8% | 742,021 | 0.0% | 0.52% | -37.5% | |
| PSDV | pSivida Corp | $7,542,000 | +5.6% | 2,665,000 | 0.0% | 0.52% | -16.5% | |
| FPRX | Sell | FIVE PRIME THERAPEUTICS INC | $7,006,000 | -62.0% | 169,439 | -62.7% | 0.49% | -70.0% |
| NEPT | NEPTUNE TECHNOLOGIES BIORESO | $6,885,000 | +2.0% | 6,750,444 | 0.0% | 0.48% | -19.4% | |
| AKBA | Buy | AKEBIA THERAPEUTICS INC | $6,684,000 | -14.2% | 893,600 | +3.3% | 0.46% | -32.3% |
| SELB | New | SELECTA BIOSCIENCES INC | $6,296,000 | – | 450,000 | +100.0% | 0.44% | – |
| AXGT | AXOVANT SCIENCES LTD | $6,227,000 | +11.8% | 485,000 | 0.0% | 0.43% | -11.5% | |
| MYOK | MYOKARDIA INC | $6,235,000 | +15.8% | 502,894 | 0.0% | 0.43% | -8.5% | |
| ZYNE | ZYNERBA PHARMACEUTICALS INC | $5,818,000 | -27.5% | 849,350 | 0.0% | 0.40% | -42.8% | |
| FWP | Buy | FORWARD PHARMA A/Ssponsored adr | $5,658,000 | +78.7% | 311,400 | +67.1% | 0.39% | +41.0% |
| New | ACADIA PHARMACEUTICALS INC | $5,364,000 | – | 165,240 | +100.0% | 0.37% | – | |
| SUPN | Buy | SUPERNUS PHARMACEUTICALS INC | $5,093,000 | +67.0% | 250,000 | +25.0% | 0.35% | +31.7% |
| FOMX | New | FOAMIX PHARMACEUTICALS LTD | $5,048,000 | – | 795,000 | +100.0% | 0.35% | – |
| CLLS | Buy | CELLECTIS S Asponsored ads | $4,879,000 | +5850.0% | 183,507 | +6025.1% | 0.34% | +4728.6% |
| NEOS | Buy | NEOS THERAPEUTICS INC | $4,611,000 | +327.3% | 626,876 | +526.9% | 0.32% | +236.8% |
| ADHD | ALCOBRA LTD | $4,617,000 | +18.5% | 1,028,272 | 0.0% | 0.32% | -6.4% | |
| ANTH | ANTHERA PHARMACEUTICALS INC | $4,611,000 | -14.6% | 1,492,156 | 0.0% | 0.32% | -32.5% | |
| ONS | New | ONCOBIOLOGICS INC | $4,463,000 | – | 1,312,763 | +100.0% | 0.31% | – |
| CLSD | New | CLEARSIDE BIOMEDICAL INC | $4,450,000 | – | 634,808 | +100.0% | 0.31% | – |
| ASSEMBLY BIOSCIENCES INC | $4,412,000 | +10.5% | 795,000 | 0.0% | 0.31% | -12.6% | ||
| NEURODERM LTD | $4,388,000 | +15.1% | 270,000 | 0.0% | 0.30% | -9.0% | ||
| TSRO | New | TESARO INCput | $4,203,000 | – | 50,000 | +100.0% | 0.29% | – |
| ABEO | Abeona Therapeutics Inc | $4,159,000 | -7.8% | 1,762,881 | 0.0% | 0.29% | -27.3% | |
| AGRX | Buy | AGILE THERAPEUTICS INC | $3,914,000 | +260.1% | 514,288 | +193.9% | 0.27% | +185.3% |
| ANIP | Sell | ANI PHARMACEUTICALS INC | $3,749,000 | -2.3% | 67,161 | -41.1% | 0.26% | -22.8% |
| TKAI | Buy | TOKAI PHARMACEUTICALS INC | $3,642,000 | +33.7% | 661,041 | +36.2% | 0.25% | +5.4% |
| GNVC | GENVEC INC | $3,447,000 | +604.9% | 606,644 | 0.0% | 0.24% | +455.8% | |
| CASC | New | Cascadian Therapeutics Inc | $3,220,000 | – | 3,414,121 | +100.0% | 0.22% | – |
| PTI | PROTEOSTASIS THERAPEUTICS IN | $3,033,000 | +25.9% | 250,000 | 0.0% | 0.21% | -0.5% | |
| AVEO | New | AVEO PHARMACEUTICALS INC | $2,987,000 | – | 3,108,808 | +100.0% | 0.21% | – |
| INNL | New | INNOCOLL HLDGS PLC | $2,808,000 | – | 560,000 | +100.0% | 0.20% | – |
| CEMP | Buy | CEMPRA INC | $2,803,000 | +6.7% | 170,000 | +13.3% | 0.19% | -16.0% |
| ARDELYX INC | $2,758,000 | +12.3% | 315,955 | 0.0% | 0.19% | -11.2% | ||
| XENE | Buy | XENON PHARMACEUTICALS INC | $2,553,000 | +77.5% | 432,800 | +110.3% | 0.18% | +40.5% |
| New | ADMA BIOLOGICS INC | $2,371,000 | – | 398,394 | +100.0% | 0.16% | – | |
| RXDX | Sell | IGNYTA INC | $2,359,000 | -74.1% | 435,260 | -67.7% | 0.16% | -79.5% |
| IONS | New | Ionis Pharmaceuticals Ord Shsput | $2,329,000 | – | 100,000 | +100.0% | 0.16% | – |
| PRTO | PROTEON THERAPEUTICS INC | $2,208,000 | +3.7% | 275,000 | 0.0% | 0.15% | -18.2% | |
| MGCD | MGC DIAGNOSTICS CORP | $2,193,000 | +7.2% | 336,287 | 0.0% | 0.15% | -15.1% | |
| ALLIQUA BIOMEDICAL INC | $2,152,000 | +36.6% | 1,921,951 | 0.0% | 0.15% | +8.0% | ||
| PGNX | New | PROGENICS PHARMACEUTICALSput | $2,110,000 | – | 500,000 | +100.0% | 0.15% | – |
| EIGR | EIGER BIOPHARMACEUTICALS INC | $2,079,000 | +18.2% | 104,920 | 0.0% | 0.14% | -6.5% | |
| RLYP | New | RELYPSA INCput | $1,850,000 | – | 100,000 | +100.0% | 0.13% | – |
| AFMD | New | AFFIMED N V | $1,821,000 | – | 734,301 | +100.0% | 0.13% | – |
| DSCI | DERMA SCIENCES INC | $1,706,000 | +27.2% | 432,884 | 0.0% | 0.12% | 0.0% | |
| MDGN | New | MEDGENICS INC | $1,665,000 | – | 300,000 | +100.0% | 0.12% | – |
| PETX | Sell | ARATANA THERAPEUTICS INC | $1,621,000 | +0.6% | 256,500 | -12.1% | 0.11% | -20.6% |
| New | ABIOMED INC | $1,607,000 | – | 14,700 | +100.0% | 0.11% | – | |
| CBPO | CHINA BIOLOGIC PRODS INC | $1,488,000 | -7.2% | 14,000 | 0.0% | 0.10% | -27.0% | |
| VCEL | Sell | VERICEL CORP | $1,254,000 | -82.8% | 557,342 | -55.3% | 0.09% | -86.4% |
| GMED | New | GLOBUS MED INCcl a | $1,192,000 | – | 50,000 | +100.0% | 0.08% | – |
| ARNO THERAPEUTIC INC | $1,080,000 | -20.6% | 3,463,292 | 0.0% | 0.08% | -37.0% | ||
| ABEOW | ABEONA THERAPEUTICS INC*w exp 12/19/201 | $1,071,000 | +4.3% | 1,259,636 | 0.0% | 0.07% | -17.8% | |
| BCLI | BRAINSTROM CELL THERAPEUTICS | $964,000 | -9.7% | 400,000 | 0.0% | 0.07% | -28.7% | |
| LPCN | New | LIPOCINE INCcall | $912,000 | – | 300,000 | +100.0% | 0.06% | – |
| LPCN | New | LIPOCINE INCput | $865,000 | – | 284,400 | +100.0% | 0.06% | – |
| PZRXQ | New | PHASERX INC | $852,000 | – | 200,000 | +100.0% | 0.06% | – |
| CSBR | CHAMPIONS ONCOLOGY INC | $801,000 | -40.9% | 372,597 | 0.0% | 0.06% | -52.9% | |
| LXRX | New | Lexicon Pharmaceuticals Inc | $718,000 | – | 50,000 | +100.0% | 0.05% | – |
| LCI | New | LANNET INC | $634,000 | – | 26,670 | +100.0% | 0.04% | – |
| NVLS | NIVALIS THERAPEUTICS INC | $575,000 | +10.4% | 125,000 | 0.0% | 0.04% | -13.0% | |
| MGLN | MAGELLAN HEALTH INC | $577,000 | -3.2% | 8,772 | 0.0% | 0.04% | -23.1% | |
| MCK | Sell | MCKESSON CORP | $556,000 | +11.0% | 2,979 | -6.6% | 0.04% | -11.4% |
| WCG | Sell | WELLCARE HEALTH PLANS INC | $542,000 | +7.3% | 5,056 | -7.2% | 0.04% | -13.6% |
| AET | New | AETNA INC NEW | $544,000 | – | 4,454 | +100.0% | 0.04% | – |
| UHS | UNIVERSAL HLTH SVCS INCcl b | $535,000 | +7.4% | 3,989 | 0.0% | 0.04% | -15.9% | |
| New | AMN HEALTHCARE SERVICES INC | $537,000 | – | 13,445 | +100.0% | 0.04% | – | |
| STML | STEMLINE THERAPEUTICS INC | $532,000 | +45.4% | 78,603 | 0.0% | 0.04% | +15.6% | |
| WOOF | New | VCA INC | $537,000 | – | 7,940 | +100.0% | 0.04% | – |
| VWR | VWR CORP | $539,000 | +6.7% | 18,657 | 0.0% | 0.04% | -15.9% | |
| IMMU | Sell | IMMUNOMEDICS INC | $514,000 | -85.5% | 221,700 | -84.4% | 0.04% | -88.4% |
| AGLE | New | AEGLEA BIOTHERAPEUTICS INC | $515,000 | – | 105,893 | +100.0% | 0.04% | – |
| ABC | New | AMERISOURCEBERGEN CORP | $516,000 | – | 6,500 | +100.0% | 0.04% | – |
| LH | New | LABORATORY CORP AMER HLDGS | $520,000 | – | 3,990 | +100.0% | 0.04% | – |
| CAH | Buy | CARDINAL HEALTH INC | $499,000 | +2.5% | 6,398 | +7.6% | 0.04% | -18.6% |
| Sell | ALMOST FAMILY INC | $509,000 | +4.5% | 11,942 | -8.7% | 0.04% | -18.6% | |
| CGNT | Sell | COGENTIX MED INC | $498,000 | -32.8% | 517,760 | -23.1% | 0.04% | -46.2% |
| UTHR | Sell | UNITED THERAPEUTICS CORP DEL | $503,000 | -77.4% | 4,753 | -76.2% | 0.04% | -82.1% |
| KND | New | KINDRED HEALTHCARE INC | $478,000 | – | 42,301 | +100.0% | 0.03% | – |
| HCA | Sell | HCA HOLDINGS INC | $478,000 | -14.8% | 6,202 | -13.7% | 0.03% | -32.7% |
| UNH | Sell | UNITEDHEALTH GROUP INC | $456,000 | -18.6% | 3,231 | -25.7% | 0.03% | -34.7% |
| MOH | Buy | MOLINA HEALTHCARE INC | $459,000 | -11.6% | 9,200 | +14.3% | 0.03% | -30.4% |
| SCMP | Buy | SUCAMPO PHARMACEUTICALS INCcl a | $451,000 | +5537.5% | 41,096 | +5314.5% | 0.03% | +3000.0% |
| PAHC | New | PHIBRO ANIMAL HEALTH CORP | $453,000 | – | 24,300 | +100.0% | 0.03% | – |
| Sell | ANTHEM INC | $447,000 | -14.2% | 3,400 | -9.3% | 0.03% | -32.6% | |
| CRL | Sell | CHARLES RIV LABS INTL INC | $452,000 | -4.6% | 5,482 | -12.2% | 0.03% | -26.2% |
| THC | New | TENET HEALTHCARE CORP | $448,000 | – | 16,200 | +100.0% | 0.03% | – |
| OPHT | New | OPHTHOTECH CORP | $416,000 | – | 8,145 | +100.0% | 0.03% | – |
| ENZ | New | ENZO BIOCHEM INC | $401,000 | – | 67,113 | +100.0% | 0.03% | – |
| SCYX | SCYNEXIS INC | $380,000 | -46.1% | 175,000 | 0.0% | 0.03% | -58.1% | |
| FCAU | FIAT CHRYSLER AUTOMOBILES N | $379,000 | -24.2% | 62,000 | 0.0% | 0.03% | -40.9% | |
| CNC | CENTENE CORP DEL | $353,000 | +15.7% | 4,948 | 0.0% | 0.02% | -11.1% | |
| ACST | ACASTI PHARMA INCcl a new | $336,000 | -6.7% | 236,559 | 0.0% | 0.02% | -28.1% | |
| CLDX | New | CELLDEX THERAPEUTICS INC NEW | $312,000 | – | 71,124 | +100.0% | 0.02% | – |
| NTLA | New | INTELLIA THERAPEUTICS INC | $320,000 | – | 15,000 | +100.0% | 0.02% | – |
| MACK | MERRIMACK PHARMACEUTICALS IN | $270,000 | -35.6% | 50,000 | 0.0% | 0.02% | -48.6% | |
| RACE | FERRARI N V | $254,000 | -1.9% | 6,200 | 0.0% | 0.02% | -21.7% | |
| NVAX | New | NOVAVAX INC | $233,000 | – | 32,000 | +100.0% | 0.02% | – |
| MYL | New | MYLAN N V | $216,000 | – | 5,000 | +100.0% | 0.02% | – |
| ONSIW | New | ONCOBIOLOGICS INC*w exp 02/18/201 | $212,000 | – | 462,500 | +100.0% | 0.02% | – |
| ONSIZ | New | ONCOBIOLOGICS INC*w exp 05/18/201 | $202,000 | – | 462,500 | +100.0% | 0.01% | – |
| New | PERNIX THERAPEUTICS HLDGS INdbcv 4.250% 4/0 | $200,000 | – | 1,000,000 | +100.0% | 0.01% | – | |
| DRAD | DIGIRAD CORP | $129,000 | +4.0% | 24,988 | 0.0% | 0.01% | -18.2% | |
| New | ABBOTT LABS | $120,000 | – | 3,040 | +100.0% | 0.01% | – | |
| PPHM | Buy | PEREGRINE PHARMACEUTICALS IN | $81,000 | +710.0% | 224,332 | +822.0% | 0.01% | +500.0% |
| DPLO | New | DIPLOMAT PHARMACY INC | $76,000 | – | 2,175 | +100.0% | 0.01% | – |
| GNCA | Sell | GENOCEA BIOSCIENCES INC | $71,000 | -98.2% | 17,313 | -96.6% | 0.01% | -98.6% |
| IMGN | New | IMMUNOGEN INC | $79,000 | – | 25,745 | +100.0% | 0.01% | – |
| ZLTQ | Sell | ZELTIQ AESTHETICS INC | $72,000 | -97.8% | 2,638 | -97.8% | 0.01% | -98.3% |
| AIMT | New | AIMMUNE THERAPEUTICS INC | $70,000 | – | 6,448 | +100.0% | 0.01% | – |
| HLF | HERBALIFE LTD | $73,000 | -5.2% | 1,250 | 0.0% | 0.01% | -28.6% | |
| ABBV | New | ABBVIE INC | $77,000 | – | 1,250 | +100.0% | 0.01% | – |
| AVXS | Sell | AVEXIS INC | $58,000 | -98.6% | 1,515 | -99.0% | 0.00% | -98.9% |
| CORT | New | CORCEPT THERAPEUTICS INC | $60,000 | – | 11,000 | +100.0% | 0.00% | – |
| New | ATARA BIOTHERAPEUTICS INC | $56,000 | – | 2,500 | +100.0% | 0.00% | – | |
| JUNO | New | JUNO THERAPEUTICS INC | $43,000 | – | 1,113 | +100.0% | 0.00% | – |
| MCRB | New | SERES THERAPEUTICS INC | $45,000 | – | 1,540 | +100.0% | 0.00% | – |
| DVAX | New | DYNAVAX TECHNOLOGIES CORP | $36,000 | – | 2,499 | +100.0% | 0.00% | – |
| BTX | New | BIOTIME INC | $36,000 | – | 13,740 | +100.0% | 0.00% | – |
| New | SEVION THERAPEUTICS | $12,000 | – | 59,220 | +100.0% | 0.00% | – | |
| GKOS | New | GLAUKOS CORP | $9,000 | – | 300 | +100.0% | 0.00% | – |
| CAPR | CAPRICOR THERAPEUTICS INC | $16,000 | +60.0% | 4,000 | 0.0% | 0.00% | 0.0% | |
| New | AVINGER INC | $13,000 | – | 1,062 | +100.0% | 0.00% | – | |
| NPCUF | New | ALLON THERAPEUTICS | $0 | – | 751,124 | +100.0% | 0.00% | – |
| INGN | INOGEN INC | $6,000 | 0.0% | 125 | 0.0% | 0.00% | -100.0% | |
| ZIOP | New | ZIOPHARM ONCOLOGY INC | $5,000 | – | 1,000 | +100.0% | 0.00% | – |
| TNGNQ | New | TENGION INC | $1,000 | – | 1,826,399 | +100.0% | 0.00% | – |
| VYGR | New | VOYAGER THERAPEUTICS INC | $7,000 | – | 650 | +100.0% | 0.00% | – |
| FLKS | FLEX PHARMA INC | $2,000 | -33.3% | 237 | 0.0% | 0.00% | – | |
| TTNP | Exit | TITAN PHARMACEUTICALS INC DE | $0 | – | -1 | -100.0% | 0.00% | – |
| ZBH | Exit | ZIMMER BIOMET HLDGS INC | $0 | – | -156 | -100.0% | -0.00% | – |
| NSPH | Exit | NANOSPHERE INC | $0 | – | -35,379 | -100.0% | -0.00% | – |
| CPRX | Exit | CATALYST PHARMACEUTICALS INC | $0 | – | -51,200 | -100.0% | -0.01% | – |
| AAVL | Exit | AVALANCHE BIOTECHNOLOGIES IN | $0 | – | -20,000 | -100.0% | -0.01% | – |
| MYGN | Exit | MYRIAD GENETICS INC | $0 | – | -3,333 | -100.0% | -0.01% | – |
| GI | Exit | ENDOCHOICE HLDGS INC | $0 | – | -25,000 | -100.0% | -0.01% | – |
| FONR | Exit | FONAR CORP | $0 | – | -8,473 | -100.0% | -0.01% | – |
| CRIS | Exit | CURIS INC | $0 | – | -100,000 | -100.0% | -0.01% | – |
| MNKKQ | Exit | MALLINCKRODT PUB LTD CO | $0 | – | -2,673 | -100.0% | -0.01% | – |
| AKAOQ | Exit | ACHAOGEN INC | $0 | – | -60,000 | -100.0% | -0.02% | – |
| ELGX | Exit | ENDOLOGIX INC | $0 | – | -25,000 | -100.0% | -0.02% | – |
| TNDM | Exit | TANDEM DIABETES CARE INC | $0 | – | -25,000 | -100.0% | -0.02% | – |
| GTS | Exit | TRIPLE-S MGMT CORPcl b | $0 | – | -10,605 | -100.0% | -0.02% | – |
| VTL | Exit | VITAL THERAPIES INC | $0 | – | -29,968 | -100.0% | -0.02% | – |
| BVX | Exit | BOVIE MEDICAL CORP | $0 | – | -162,700 | -100.0% | -0.02% | – |
| Exit | TRILLIUM THERAPEUTICS INC | $0 | – | -30,000 | -100.0% | -0.02% | – | |
| DRNA | Exit | DICERNA PHARMACEUTICALS INC | $0 | – | -50,000 | -100.0% | -0.02% | – |
| APHB | Exit | AMPLIPHI BIOSCIENCES CORP | $0 | – | -80,000 | -100.0% | -0.03% | – |
| SPY | Exit | SPDR S&P 500 ETF TRtr unit | $0 | – | -1,600 | -100.0% | -0.03% | – |
| GLMD | Exit | GALMED PHARMACEUTICALS LTD | $0 | – | -75,000 | -100.0% | -0.03% | – |
| PMC | Exit | PHARMERICA CORP | $0 | – | -16,841 | -100.0% | -0.03% | – |
| INCR | Exit | INC RESH HLDGS INCcl a | $0 | – | -11,846 | -100.0% | -0.04% | – |
| TARO | Exit | TARO PHARMACEUTICAL INDS LTD | $0 | – | -3,429 | -100.0% | -0.04% | – |
| Q | Exit | QUINTILES TRANSNATIO HLDGS I | $0 | – | -7,447 | -100.0% | -0.04% | – |
| Exit | AMEDISYS INC | $0 | – | -10,493 | -100.0% | -0.04% | – | |
| PRAH | Exit | PRA HEALTH SCIENCES INC | $0 | – | -11,751 | -100.0% | -0.04% | – |
| HOLX | Exit | HOLOGIC INC | $0 | – | -14,732 | -100.0% | -0.04% | – |
| ENTA | Exit | ENANTA PHARMACEUTICALS INC | $0 | – | -17,507 | -100.0% | -0.04% | – |
| INFI | Exit | INFINITY PHARMACEUTICALS INC | $0 | – | -100,000 | -100.0% | -0.05% | – |
| AQXP | Exit | AQUINOX PHARMACEUTICALS INC | $0 | – | -59,600 | -100.0% | -0.05% | – |
| GILD | Exit | GILEAD SCIENCES INC | $0 | – | -6,024 | -100.0% | -0.05% | – |
| ICLR | Exit | ICON PLC | $0 | – | -7,585 | -100.0% | -0.05% | – |
| AMN | Exit | AMN HEALTHCARE SERVICES INC | $0 | – | -17,428 | -100.0% | -0.05% | – |
| VNDA | Exit | VANDA PHARMACEUTICALS INC | $0 | – | -71,849 | -100.0% | -0.05% | – |
| Exit | INTEC PHARMA LTD JERUSALEM | $0 | – | -192,580 | -100.0% | -0.07% | – | |
| ABMD | Exit | ABIOMED INC | $0 | – | -9,700 | -100.0% | -0.08% | – |
| GWPH | Exit | GW PHARMACEUTICALS PLCads | $0 | – | -13,109 | -100.0% | -0.08% | – |
| VXX | Exit | BARCLAYS BK PLCipath s&p500 vix | $0 | – | -60,000 | -100.0% | -0.09% | – |
| NVTA | Exit | INVITAE CORP | $0 | – | -118,366 | -100.0% | -0.11% | – |
| RGLS | Exit | REGULUS THERAPEUTICS INC | $0 | – | -325,407 | -100.0% | -0.20% | – |
| ACAD | Exit | ACADIA PHARMACEUTICALS INCput | $0 | – | -200,000 | -100.0% | -0.24% | – |
| WBA | Exit | WALGREENS BOOTS ALLIANCE INC | $0 | – | -35,292 | -100.0% | -0.26% | – |
| OMER | Exit | OMEROS CORP | $0 | – | -200,000 | -100.0% | -0.27% | – |
| Exit | AFFIMED THERAPEUTICS BVsponsored adr | $0 | – | -821,201 | -100.0% | -0.27% | – | |
| OTIC | Exit | OTONOMY INC | $0 | – | -235,986 | -100.0% | -0.31% | – |
| SPNC | Exit | SPECTRANETICS CORP | $0 | – | -267,070 | -100.0% | -0.34% | – |
| ONTY | Exit | ONCOTHYREON INC | $0 | – | -3,414,121 | -100.0% | -0.38% | – |
| Exit | AMGEN INC | $0 | – | -30,000 | -100.0% | -0.40% | – | |
| Exit | ALDER BIOPHARMACEUTICALS INCput | $0 | – | -200,000 | -100.0% | -0.43% | – | |
| CELG | Exit | CELGENE CORP | $0 | – | -50,000 | -100.0% | -0.44% | – |
| NVRO | Exit | NEVRO CORPcall | $0 | – | -100,000 | -100.0% | -0.49% | – |
| HZNP | Exit | HORIZON PHARMA PLC | $0 | – | -350,000 | -100.0% | -0.51% | – |
| MRTX | Exit | MIRATI THERAPEUTICS INC | $0 | – | -273,000 | -100.0% | -0.51% | – |
| NVO | Exit | NOVO-NORDISK A Sadr | $0 | – | -116,660 | -100.0% | -0.56% | – |
| ACAD | Exit | ACADIA PHARMACEUTICALS INC | $0 | – | -255,240 | -100.0% | -0.63% | – |
| Exit | BAXTER INTERNATIONAL INCcall | $0 | – | -175,400 | -100.0% | -0.63% | – | |
| Exit | BAXTER INTL INC | $0 | – | -220,000 | -100.0% | -0.79% | – | |
| HUM | Exit | HUMANA INC | $0 | – | -110,000 | -100.0% | -1.76% | – |
| AGN | Exit | ALLERGAN PLC | $0 | – | -155,000 | -100.0% | -3.64% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-08-11
About Perceptive Advisors
Perceptive Advisors is a New York-based hedge fund that specializes in healthcare investments. The company was founded in 1999 by Joseph Edelman, who serves as the CEO and Chief Investment Officer. Since its inception, Perceptive Advisors has become one of the most successful healthcare-focused hedge funds in the world, with over $5 billion in assets under management.
The company's investment strategy is based on a deep understanding of the healthcare industry and a focus on identifying promising companies with innovative products and technologies. Perceptive Advisors invests in a wide range of healthcare sectors, including biotechnology, pharmaceuticals, medical devices, and healthcare services.
One of the key factors behind Perceptive Advisors' success is its team of experienced professionals. In addition to Joseph Edelman, the company's leadership team includes Adam Stone, the COO, and Jeremy Goldberg, the Chief Scientific Officer. The team also includes a group of highly skilled analysts and researchers who are experts in their respective fields.
Perceptive Advisors has a strong track record of generating high returns for its investors. However, it is important to note that investing in hedge funds carries significant risks, and investors should carefully consider their investment objectives and risk tolerance before investing. As with any investment, it is important to conduct thorough research and seek the advice of a qualified financial advisor before making any investment decisions.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES SHARES | 42 | Q3 2023 | 15.7% |
| AMICUS THERAPEUTICS SHARES | 39 | Q3 2023 | 14.0% |
| ALDEYRA THERAPEUTICS SHARES | 35 | Q3 2023 | 3.3% |
| QUOTIENT TECHNOLOGY INC | 34 | Q3 2022 | 2.7% |
| GLOBAL BLOOD THERAPEUTICS SHARES | 29 | Q3 2022 | 9.3% |
| ADMA BIOLOGICS SHARES | 29 | Q3 2023 | 1.4% |
| RETROPHIN SHARES | 28 | Q3 2020 | 5.5% |
| DBV TECHNOLOGIES SA-SPON ADR | 28 | Q3 2021 | 1.8% |
| VBI VACCINES SHARES | 27 | Q1 2023 | 2.8% |
| IOVANCE BIOTHERAPEUTICS INC | 26 | Q3 2023 | 9.1% |
View Perceptive Advisors's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| CHEMBIO DIAGNOSTICS, INC.Sold out | May 04, 2023 | 0 | 0.0% |
| VBI Vaccines Inc/BC | April 07, 2023 | 43,509,553 | 16.7% |
| Landos Biopharma, Inc. | March 30, 2023 | 14,869,915 | 47.7% |
| REATA PHARMACEUTICALS INC | March 07, 2023 | 2,083,799 | 6.5% |
| AGILE THERAPEUTICS INCSold out | February 14, 2023 | 0 | 0.0% |
| ALBIREO PHARMA, INC. | February 14, 2023 | 1,757,160 | 8.5% |
| BELLUS Health Inc. | February 14, 2023 | 8,891,027 | 7.1% |
| CinCor Pharma, Inc. | February 14, 2023 | 2,576,325 | 5.9% |
| Coherus BioSciences, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| CONCERT PHARMACEUTICALS, INC. | February 14, 2023 | 1,800,000 | 3.6% |
View Perceptive Advisors's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-17 |
| SC 13D/A | 2024-04-17 |
| 4 | 2024-04-15 |
| SC 13G/A | 2024-04-15 |
| SC 13G | 2024-04-15 |
| SC 13D/A | 2024-04-10 |
| 4 | 2024-04-08 |
| 4 | 2024-04-03 |
| SC 13D/A | 2024-04-03 |
| SC 13D | 2024-03-20 |
View Perceptive Advisors's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.